localization in human nasal mucosa, by polymerase chain reaction (PCR) and immunohistochemistry.Human turbinates were obtained after turbinectomy from 6 patients with nasal obstruction refractory to medical therapy. Total RNA was isolated from human nasal mucosa, and CysLT2 receptor mRNA was detected in these tissues by using reverse transcriptase-PCR analysis. To identify the cells expressing CysLT2 receptor protein, double immunostaining was performed using anti-CysLT2 receptor antibody and anti-CD31 (endothelial cell) antibody. Results: Reverse transcriptase-PCR analysis of total nasal RNA demonstrated the expression of CysLT2 receptor mRNA. The immunohistochemical studies revealed that anti-CysLT2 receptor antibody mainly labeled blood vessels.
National Institute of Pediatrics, Mexico City, Mexico. Background: X-linked lymphoproliferative disease (XLP) is a primary immunodeficiency presenting with a variety of clinical manifestations, the most common being dysgammaglobulinemia and B-cell lymphoma. The first gene causing XLP, when defective, was termed SH2D1A or SAP for signaling lymphocyte activation molecule (SLAM)-associated protein. The absence of SH2D1A leads to an overwhelming and uncontrolled TH1-shifted cytotoxic immune response, which might, at least in part, explain the severe clinical picture. A second gene, XIAP (X-linked inhibitor of apoptosis), was later identified. Methods: An 8 year old Mexican boy was admitted in June 2008 for bronchopneumonia, with no previous history of recurrent or severe infections. He had a family history of a brother deceased at 7 years from fulminate hepatitis, who was diagnosed with agammaglobulinemia. A laboratory evaluation for primary immunodeficiency was made, including serum immunoglobulins: IgG 30 mg/dL, IgA ,5 mg/dL IgM 8.6 mg/dL; and flow citometry for lymphocyte subpopulations: CD31 2590 mm 3 (56%) CD41 1004 mm 3 (42%), CD81 1267 mm 3 (53%) CD16/56 171mm 3 (41%) CD191 1493 mm 3 (35%). The patient was started on monthly intravenous gammaglobulin (IVIG) therapy. He was admitted in December 2008 with fever and severe abdominal pain; an exploratory laparotomy revealed a rectal-sigmoid tumor. The biopsy reported an atypical Burkitt lymphoma (Immunophenotype "B": Bcl 21, CD101) with surgical margins negative for malignancy. Bone marrow aspirate and biopsy were negative for malignancy. In February 2009, management with chemotherapy was started with the diagnosis of Burkitt's lymphoma stage III. Patient received 6 courses of chemotherapy with complete response to induction; for consolidation, 4 doses of rituximab were given. PCR amplification and direct automated sequencing by the Sanger method was performed in both genes known to be responsible for XLP in chromosome X. Results: A hemizygous splice-site deletion in SAP was found, in intron 2: c.187_201110del25, which deletes exon 2 splice donor site, and is predicted to result in the skipping of exon 2, and thus in a truncated, nonfunctional protein. XIAP was also sequenced and no mutation was found. Conclusions: Final diagnosis: XLP.The patient is currently in the program for hematopoietic stem-cell transplantation. Inmunologia, Instituto Nacional de Peditría, Mexico City, Mexico. Background: To identify the pattern of transmission in male CGD patients and the CGD X-linked carriers among their female relatives. Methods: Through the 123 Dihydrorodamine assay in blood samples of the female relatives of CGD patients we identified a positive bimodal pattern in each woman. A positive bimodal pattern reveled 2 points, first, that the pattern of transmission in the patients was X-linked, second, that the woman was a carrier. Results: We analyzed 59 female relatives of 18 male CGD patients. Among 14 CGD males we found 28 women whit a positive bimodal pattern; in 4 male CGD patients we did not find any relative with a positive bimodal pattern. Conclusions: 123 DHR assay is an accessible and quickly technique to determinate the pattern of transmission and the carriers in X-CGD. However a negative finding of a bimodal pattern in the female relatives suggests an autosomal recessive pattern but it does not rule out an X-CDD because of a novo mutation or non-random (skewed) X-chromosome inactivation. Definitive diagnosis is based on candidate gene sequencing. (cytokines, chemokines, etc) are affected, leading to a low capacity to eliminate microorganisms and a high susceptibility to infection diseases. Most of the PID are multifactorial entities were the environmental and multiple genetic factor are involved. The single nucleotide polymorphisms (SNPs) analysis in case and control groups has been increasing the knowledge of the etiopathogenesis of several diseases and the opportunity to identify molecular markers useful in the clinical diagnosis. Methods: We performed a case control study including 19 pediatric patients with IgE deficiency (5 U/mL), and 180 healthy controls. 25 SNPs distributed in the IL-13, IL-10, IL-5, IL4, FCER1B, INF g, GM-CSF, STAT 3, GATA 3 and TIK-2 were analyzed. Genotyping was performed using sondas TaqMan. Hardy-Weinberg Equilibrium (HWE) and statistical significance were evaluated using FINETTI and STATCAL software. Results: All genotypes, both in cases and controls were in HWE. We documented statistically significant differences in the distribution of the SNPs located in IL-4 rs4986964, P ¼ 0.018, OR ¼ 14.74, IL-4R, rs18005010, P ¼ 0.018, OR ¼ 2.22, FCER-1B, rs556917, P ¼ 0.00001, OR ¼ 16.9, GM-CSF, STAT-3 and GATA-3 genes: GMFCS-130 (P ¼ 4986964, OR ¼ 0.22), STAT-3 rs2293152 (P ¼ 5.06 · 10 29 , OR ¼ 6.18), GATA-3 rs2229360 (P ¼ 0.005, OR ¼ 13.52). The highest difference was found in the T allele of rs556917, which was more frequent in cases than controls (42.1 and 1.5%, respectively, P ¼ 0.00001 OR ¼ 16.907, 95% CI, 5.02-54.93). Interestingly, the C allele of 4986964 (IL-4) increased significantly in homozygote genotype (C: OR ¼ 14.74, 95% CI, 2.38-91.234, P ¼ 0.018 to CC OR ¼ 29.4, 95% CI, 1.154-749.32, P ¼ 0.002). Conclusions: Our results suggest that SNPs located in the genes involved in the IgE production are risk genetic factor to IgE immunodeficiency. Increasing of the sample size is currently to get solid conclusions. 
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